Clinician-led weight management
Medical weight-management treatments, explained clearly.
Prescription options considered carefully by UK-registered clinicians, alongside practical guidance and ongoing support.
A consultation is required before any prescription decision.
A considered approach
The right treatment starts with knowing you.
The Slimming Doctor
Family-run, online UK medical clinic
Treatment options
Different options. One personal approach.
We can discuss prescription treatments with you if they may be suitable following a full clinical assessment.
Our clinicians assess and prescribe where appropriate. Treatment is supplied through regulated UK prescribing and dispensing processes, with continued support after delivery.
Wegovy
Semaglutide
A once-weekly injectable GLP-1 treatment licensed in the UK for weight management.
From £185/month
View treatmentMounjaro
Tirzepatide
The first and only dual GIP and GLP-1 receptor agonist, taken as a once-weekly injection.
From £215/month
View treatmentWegovy Pill
Semaglutide
The same active ingredient as Wegovy, in a once-daily tablet — for those who prefer to avoid injections.
From £185/month
View treatmentFoundayo
Orforglipron
A once-daily oral GLP-1 tablet, taken without the food and water restrictions required by some other oral GLP-1 treatments.
From £185/month
View treatmentPricing may vary by dose and clinical suitability. Your clinician will confirm costs at each stage.
Understanding the options
What are GLP-1 medicines?
GLP-1 receptor agonists are prescription-only medicines licensed in the UK for certain adults living with obesity or weight-related health conditions. They may support weight management alongside dietary and lifestyle changes.
Treatment is offered only after clinical assessment and where it is considered appropriate.
Appetite
May help reduce appetite
Fullness
May increase feelings of fullness
Supervision
Used with clinical support
Compare your options
Injection or tablet — see how they differ.
Your clinician will help you choose based on your health and preferences. Here's how the options compare.
| Treatment | Form | Generic name | From | Good to know |
|---|---|---|---|---|
| Wegovy | Weekly Injection | Semaglutide | £185/month | A once-weekly injectable GLP-1 treatment licensed in the UK for weight management. |
| Mounjaro | Weekly Injection | Tirzepatide | £215/month | The first and only dual GIP and GLP-1 receptor agonist, taken as a once-weekly injection. |
| Wegovy Pill | Daily Tablet | Semaglutide | £185/month | For patients who would rather not self-inject, this offers the same active ingredient as Wegovy in tablet form. |
| Foundayo | Daily Tablet | Orforglipron | £185/month | A newer oral option for patients who want tablet-based treatment without fasting or water-timing restrictions. |
Important to know: treatment is not suitable for everyone, a full medical assessment is required before any prescribing decision, we do not prescribe for cosmetic weight loss, and results vary between individuals and are not guaranteed.
Clear answers
Frequently asked questions
We want you to feel informed before deciding whether to take the next step.
Suitability and assessment
Understand who treatment may be suitable for and what we review before prescribing.
Medication and side effects
Learn what GLP-1 medicines do, how they are supplied, and what to expect.
Safety, regulation and privacy
Find out how the service is governed and how concerns are handled.
Your next step
You won’t be rushed into a decision.
Whether you're weighing up an injection or a tablet, a UK-registered clinician will confirm what's appropriate for you before anything is prescribed.